Lars Wienbrandt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lars Wienbrandt has a total of 175 co-authors. Here are the top co-authors by number of shared publications:
- David Ellinghaus
Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany
13 shared publications - Jan Christian Kässens
Medical Department II, Hematology and Oncology University Medical Center Schleswig‐Holstein, Campus Kiel Kiel Germany
13 shared publications Manfred Schimmler
Kiel University. Department of Computer Science, Germany
13 shared publicationsDavid Ellinghaus
Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein, Rosalind-Franklin-Str. 12, 24105 Kiel, Germany
10 shared publicationsBertil Schmidt
Johannes Gutenberg University Mainz, Institute of Computer Science, Germany
7 shared publications- Jorge González-Domínguez
CITIC, Computer Architecture Group, Universidade da Coruña, A Coruña, Spain
7 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (11) , 2778-2783
A haplotype reference panel constructed from 490,319 UK Biobank genomes improves genotype imputation for global populations
Here we constructed a genotype imputation reference panel from whole-genome sequencing data from 490,319 UK Biobank (UKB) participants 1 and enabled both standalone and cloud-based phasing and imputation through EagleImp 2 and EagleImp-RAP within the UK Biobank Research Analysis Platform. The UKB reference panel achieves lower phasing switch error rates than the widely used TOPMed r3 panel (133,597 individuals) for all global superpopulations except AMR and for 25 of 26 1000 Genomes Project subpopulations. Imputation accuracy, measured by MAE, improved for 4 of 5 superpopulations and 12 subpopulations for variants with minor allele frequencies down to 0.01%. Estimated squared correlation further improved across all 5 superpopulations and 22 subpopulations, with the largest gains in East and South Asian populations. Reimputation of COVID-19 genome-wide association study datasets from Italy, Germany, Spain and Norway 3,4 demonstrated that common-variant imputation remains unsaturated, enhancing the discovery of genome-wide significant loci and improving fine-mapping resolution.
- 30 October 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (11) , 2778-2783
Open AccessA haplotype reference panel constructed from 490,319 UK Biobank genomes improves genotype imputation for global populations
Here we constructed a genotype imputation reference panel from whole-genome sequencing data from 490,319 UK Biobank (UKB) participants 1 and enabled both standalone and cloud-based phasing and imputation through EagleImp 2 and EagleImp-RAP within the UK Biobank Research Analysis Platform. The UKB reference panel achieves lower phasing switch error rates than the widely used TOPMed r3 panel (133,597 individuals) for all global superpopulations except AMR and for 25 of 26 1000 Genomes Project subpopulations. Imputation accuracy, measured by MAE, improved for 4 of 5 superpopulations and 12 subpopulations for variants with minor allele frequencies down to 0.01%. Estimated squared correlation further improved across all 5 superpopulations and 22 subpopulations, with the largest gains in East and South Asian populations. Reimputation of COVID-19 genome-wide association study datasets from Italy, Germany, Spain and Norway 3,4 demonstrated that common-variant imputation remains unsaturated, enhancing the discovery of genome-wide significant loci and improving fine-mapping resolution.
- 26 June 2026
- Published by Springer Nature
- p. 213-227
A Data-Driven Framework for Optimal Covariate Clustering in Genome-Wide Association Interaction Studies
- 26 June 2026
- Published by Springer Nature
- p. 213-227
A Data-Driven Framework for Optimal Covariate Clustering in Genome-Wide Association Interaction Studies
- Open Access
A haplotype reference panel constructed from 490,319 UK Biobank genomes improves genotype imputation for global populations
We constructed a genotype imputation reference panel from whole-genome sequence data of 490,319 UK Biobank participants and enabled both standalone and cloud-based phasing and imputation through EagleImp and EagleImp-RAP within the UK Biobank Research Analysis Platform. The UK Biobank reference panel achieves lower phasing switch error rates than the widely used TOPMed r3 panel (133,597 individuals) for all global superpopulations except AMR and for 25 of 26 1000 Genomes Project subpopulations. Imputation accuracy, measured by mean absolute error, improved for four of five superpopulations and 12 subpopulations for variants with minor allele frequencies down to 0.01%. Estimated squared correlation further improved across all five superpopulations and 22 subpopulations, with the largest gains in East and South Asian populations. Re-imputation of COVID-19 GWAS datasets from Italy, Germany, Spain and Norway demonstrated that common-variant imputation remains unsaturated, enhancing the discovery of genome-wide significant loci and improving fine-mapping resolution.
Open AccessA haplotype reference panel constructed from 490,319 UK Biobank genomes improves genotype imputation for global populations
We constructed a genotype imputation reference panel from whole-genome sequence data of 490,319 UK Biobank participants and enabled both standalone and cloud-based phasing and imputation through EagleImp and EagleImp-RAP within the UK Biobank Research Analysis Platform. The UK Biobank reference panel achieves lower phasing switch error rates than the widely used TOPMed r3 panel (133,597 individuals) for all global superpopulations except AMR and for 25 of 26 1000 Genomes Project subpopulations. Imputation accuracy, measured by mean absolute error, improved for four of five superpopulations and 12 subpopulations for variants with minor allele frequencies down to 0.01%. Estimated squared correlation further improved across all five superpopulations and 22 subpopulations, with the largest gains in East and South Asian populations. Re-imputation of COVID-19 GWAS datasets from Italy, Germany, Spain and Norway demonstrated that common-variant imputation remains unsaturated, enhancing the discovery of genome-wide significant loci and improving fine-mapping resolution.
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1) , vbag172
GWAIS-Web: a free and secure web service for ultra-fast and large-scale genome-wide association interaction studies
Summary: Genome-wide association interaction studies (GWAIS) are essential for identifying non-additive genetic effects underlying complex diseases, but exhaustive screening of SNP-SNP combinations across millions of variants is computationally demanding. We present GWAIS-Web, a free, ultra-fast, privacy-compliant web service that enables genome-wide screening of pairwise or third-order interactions for large case-control GWAS datasets. GWAIS-Web combines algorithmic advances with GPU- and FPGA-accelerated implementations, achieving speedups of more than three orders of magnitude compared to established CPU-based approaches and reducing analysis runtimes from years to days. The service supports multiple widely used epistasis detection methods, including PLINK’s logistic regression test and BOOST, and provides practical options such as LD-based SNP filtering, region-specific analyses and the simultaneous execution of multiple methods within a single run. Availability and implementation: GWAIS-Web is freely available at https://hybridcomputing.ikmb.uni-kiel.de. Source code for the stand-alone CPU/GPU implementation and the FPGA extension is provided at https://github.com/ikmb/hybridgwais and https://github.com/ikmb/hybridgwais-fpga.
- 7 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1) , vbag172
Open AccessGWAIS-Web: a free and secure web service for ultra-fast and large-scale genome-wide association interaction studies
Summary: Genome-wide association interaction studies (GWAIS) are essential for identifying non-additive genetic effects underlying complex diseases, but exhaustive screening of SNP-SNP combinations across millions of variants is computationally demanding. We present GWAIS-Web, a free, ultra-fast, privacy-compliant web service that enables genome-wide screening of pairwise or third-order interactions for large case-control GWAS datasets. GWAIS-Web combines algorithmic advances with GPU- and FPGA-accelerated implementations, achieving speedups of more than three orders of magnitude compared to established CPU-based approaches and reducing analysis runtimes from years to days. The service supports multiple widely used epistasis detection methods, including PLINK’s logistic regression test and BOOST, and provides practical options such as LD-based SNP filtering, region-specific analyses and the simultaneous execution of multiple methods within a single run. Availability and implementation: GWAIS-Web is freely available at https://hybridcomputing.ikmb.uni-kiel.de. Source code for the stand-alone CPU/GPU implementation and the FPGA extension is provided at https://github.com/ikmb/hybridgwais and https://github.com/ikmb/hybridgwais-fpga.
- 7 July 2025
- Published by Springer Nature
- p. 364-371
Logistic Regression with Covariate Clustering in Genome-Wide Association Interaction Studies
- 7 July 2025
- Published by Springer Nature
- p. 364-371
Logistic Regression with Covariate Clustering in Genome-Wide Association Interaction Studies
- Open Access
- 23 August 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (17) , 10144-10160
Network medicine-based epistasis detection in complex diseases: ready for quantum computing
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture, it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic single nucleotide polymorphisms (SNPs) ( 1–3). Existing statistical computational methods for EI detection are mostly limited to pairs of SNPs due to the combinatorial explosion of higher-order EIs. With NeEDL (network-based epistasis detection via local search), we leverage network medicine to inform the selection of EIs that are an order of magnitude more statistically significant compared to existing tools and consist, on average, of five SNPs. We further show that this computationally demanding task can be substantially accelerated once quantum computing hardware becomes available. We apply NeEDL to eight different diseases and discover genes (affected by EIs of SNPs) that are partly known to affect the disease, additionally, these results are reproducible across independent cohorts. EIs for these eight diseases can be interactively explored in the Epistasis Disease Atlas (https://epistasis-disease-atlas.com). In summary, NeEDL demonstrates the potential of seamlessly integrated quantum computing techniques to accelerate biomedical research. Our network medicine approach detects higher-order EIs with unprecedented statistical and biological evidence, yielding unique insights into polygenic diseases and providing a basis for the development of improved risk scores and combination therapies.
- 23 August 2024
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 52 (17) , 10144-10160
Open AccessNetwork medicine-based epistasis detection in complex diseases: ready for quantum computing
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture, it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic single nucleotide polymorphisms (SNPs) ( 1–3). Existing statistical computational methods for EI detection are mostly limited to pairs of SNPs due to the combinatorial explosion of higher-order EIs. With NeEDL (network-based epistasis detection via local search), we leverage network medicine to inform the selection of EIs that are an order of magnitude more statistically significant compared to existing tools and consist, on average, of five SNPs. We further show that this computationally demanding task can be substantially accelerated once quantum computing hardware becomes available. We apply NeEDL to eight different diseases and discover genes (affected by EIs of SNPs) that are partly known to affect the disease, additionally, these results are reproducible across independent cohorts. EIs for these eight diseases can be interactively explored in the Epistasis Disease Atlas (https://epistasis-disease-atlas.com). In summary, NeEDL demonstrates the potential of seamlessly integrated quantum computing techniques to accelerate biomedical research. Our network medicine approach detects higher-order EIs with unprecedented statistical and biological evidence, yielding unique insights into polygenic diseases and providing a basis for the development of improved risk scores and combination therapies.
- Open Access
- 5 January 2024
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 4 (1) , vbae114
Introducing field-programmable gate arrays in genotype phasing and imputation
We recently developed EagleImp, a free software that combines genotype phasing and imputation in a single tool. By introducing algorithmic and technical improvements we accelerated the classical two-step approach using Eagle2 and PBWT. Here, we demonstrate how to use Field-Programmable Gate Arrays (FPGAs) to accelerate EagleImp even further by a factor of up to 93% without loss of phasing and imputation quality. Due to the speed advantage over a not accelerated processor-based implementation, the FPGA-extension of EagleImp offers the user the ability to choose a more resource-intensive parameter setting in exchange for computation time to further improve phasing and imputation quality. EagleImp and its FPGA-extension are freely availabe at https://github.com/ikmb/eagleimp and https://github.com/ikmb/eagleimp-fpga.
- 5 January 2024
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 4 (1) , vbae114
Open AccessIntroducing field-programmable gate arrays in genotype phasing and imputation
We recently developed EagleImp, a free software that combines genotype phasing and imputation in a single tool. By introducing algorithmic and technical improvements we accelerated the classical two-step approach using Eagle2 and PBWT. Here, we demonstrate how to use Field-Programmable Gate Arrays (FPGAs) to accelerate EagleImp even further by a factor of up to 93% without loss of phasing and imputation quality. Due to the speed advantage over a not accelerated processor-based implementation, the FPGA-extension of EagleImp offers the user the ability to choose a more resource-intensive parameter setting in exchange for computation time to further improve phasing and imputation quality. EagleImp and its FPGA-extension are freely availabe at https://github.com/ikmb/eagleimp and https://github.com/ikmb/eagleimp-fpga.
- Open Access
Network medicine-based epistasis detection in complex diseases: ready for quantum computing
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture, it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic single nucleotide polymorphisms (SNPs) 1–3 . Existing statistical computational methods for EI detection are mostly limited to pairs of SNPs due to the combinatorial explosion of higher-order EIs. With NeEDL ( ne twork-based e pistasis d etection via l ocal search), we leverage network medicine to inform the selection of EIs that are an order of magnitude more statistically significant compared to existing tools and consist, on average, of five SNPs. We further show that this computationally demanding task can be substantially accelerated once quantum computing hardware becomes available. We apply NeEDL to eight different diseases and discover genes (affected by EIs of SNPs) that are partly known to affect the disease, additionally, these results are reproducible across independent cohorts. EIs for these eight diseases can be interactively explored in the Epistasis Disease Atlas ( https://epistasis-disease-atlas.com ). In summary, NeEDL is the first application that demonstrates the potential of seamlessly integrated quantum computing techniques to accelerate biomedical research. Our network medicine approach detects higher-order EIs with unprecedented statistical and biological evidence, yielding unique insights into polygenic diseases and providing a basis for the development of improved risk scores and combination therapies.
Open AccessNetwork medicine-based epistasis detection in complex diseases: ready for quantum computing
Most heritable diseases are polygenic. To comprehend the underlying genetic architecture, it is crucial to discover the clinically relevant epistatic interactions (EIs) between genomic single nucleotide polymorphisms (SNPs) 1–3 . Existing statistical computational methods for EI detection are mostly limited to pairs of SNPs due to the combinatorial explosion of higher-order EIs. With NeEDL ( ne twork-based e pistasis d etection via l ocal search), we leverage network medicine to inform the selection of EIs that are an order of magnitude more statistically significant compared to existing tools and consist, on average, of five SNPs. We further show that this computationally demanding task can be substantially accelerated once quantum computing hardware becomes available. We apply NeEDL to eight different diseases and discover genes (affected by EIs of SNPs) that are partly known to affect the disease, additionally, these results are reproducible across independent cohorts. EIs for these eight diseases can be interactively explored in the Epistasis Disease Atlas ( https://epistasis-disease-atlas.com ). In summary, NeEDL is the first application that demonstrates the potential of seamlessly integrated quantum computing techniques to accelerate biomedical research. Our network medicine approach detects higher-order EIs with unprecedented statistical and biological evidence, yielding unique insights into polygenic diseases and providing a basis for the development of improved risk scores and combination therapies.
- Open Access
GWAIS-Web : A Fast and Secure Web Service for Epistasis Detection in Genome-wide Association Interaction Studies
Motivation: Genome-wide association interaction studies (GWAIS) are becoming increasingly important as estimates of genetic interactions at the genome-wide level using genome-wide data from hundreds of thousands of individuals from large biobanks showed that non-additive genetic variance plays a role in complex human traits in addition to additive genetic effects identified in genome-wide association studies (GWAS). However, a comprehensive genome-wide search for all combinations of second-order (SNPxSNP) or third-order (SNPxSNPxSNP) associations using millions of SNP markers is a very computationally intensive task, especially when hundreds of thousands or, in the near future, even millions of individuals can be studied with GWAS datasets. The runtime so far exceeds years, even if the search is performed on a multicore CPU server system. Results: We developed GWAIS-Web , a web service for fast analysis of genome-wide interactions with case-control GWAS datasets. By using a hybrid combination of graphics-processing units (GPUs) and field-programmable gate arrays (FPGAs), GWAIS-Web speeds up epistasis detection methods for binary traits by a factor of more than 2000, allowing an exhaustive SNP-SNP GWAIS with a GWAS data set of one million SNPs and 500,000 individuals to complete within one day, which would take more than five years on a regular CPU server system. The user can choose between different methods for epistasis detection, such as logistic regression, BOOST, mutual information (MI) and others, with calculations in double precision and including on-the-fly filtering of correlated results based on linkage disequilibrium (LD). Due to the underlying common data structure of GWAIS-Web , all methods can be combined and processed together on-the-fly without increasing the runtime. The user can choose between 2nd order (pairwise) and 3rd order tests and can also limit the search to selected chromosomal regions. GWAIS-Web offers a high level of security through optional 2-factor authentication, encrypted connections and the protection of GWAS/user account data in accordance with the European General Data Protection Regulation (GDPR). Availability: GWAIS-Web is freely available at https://hybridcomputing.ikmb.uni-kiel.de . The stand-alone software HybridGWAIS can be downloaded at https://github.com/ikmb/hybridgwais . Supplementary information: Supplementary data are available online.
Open AccessGWAIS-Web : A Fast and Secure Web Service for Epistasis Detection in Genome-wide Association Interaction Studies
Motivation: Genome-wide association interaction studies (GWAIS) are becoming increasingly important as estimates of genetic interactions at the genome-wide level using genome-wide data from hundreds of thousands of individuals from large biobanks showed that non-additive genetic variance plays a role in complex human traits in addition to additive genetic effects identified in genome-wide association studies (GWAS). However, a comprehensive genome-wide search for all combinations of second-order (SNPxSNP) or third-order (SNPxSNPxSNP) associations using millions of SNP markers is a very computationally intensive task, especially when hundreds of thousands or, in the near future, even millions of individuals can be studied with GWAS datasets. The runtime so far exceeds years, even if the search is performed on a multicore CPU server system. Results: We developed GWAIS-Web , a web service for fast analysis of genome-wide interactions with case-control GWAS datasets. By using a hybrid combination of graphics-processing units (GPUs) and field-programmable gate arrays (FPGAs), GWAIS-Web speeds up epistasis detection methods for binary traits by a factor of more than 2000, allowing an exhaustive SNP-SNP GWAIS with a GWAS data set of one million SNPs and 500,000 individuals to complete within one day, which would take more than five years on a regular CPU server system. The user can choose between different methods for epistasis detection, such as logistic regression, BOOST, mutual information (MI) and others, with calculations in double precision and including on-the-fly filtering of correlated results based on linkage disequilibrium (LD). Due to the underlying common data structure of GWAIS-Web , all methods can be combined and processed together on-the-fly without increasing the runtime. The user can choose between 2nd order (pairwise) and 3rd order tests and can also limit the search to selected chromosomal regions. GWAIS-Web offers a high level of security through optional 2-factor authentication, encrypted connections and the protection of GWAS/user account data in accordance with the European General Data Protection Regulation (GDPR). Availability: GWAIS-Web is freely available at https://hybridcomputing.ikmb.uni-kiel.de . The stand-alone software HybridGWAIS can be downloaded at https://github.com/ikmb/hybridgwais . Supplementary information: Supplementary data are available online.
- Open Access
Genome-wide analysis of individual coding variants and HLA-II-associated self-immunopeptidomes in ulcerative colitis
Genome wide association studies contributed to a better understanding of the etiology of inflammatory bowel disease (IBD). While over 240 genetic associations with IBD have since been identified, functional follow-up studies are still in their infancy with the overall pathogenesis of IBD remaining unsolved. E.g., a functional understanding of the genetic association between the human leukocyte antigen (HLA) region and ulcerative colitis (UC) – one subtypes of IBD – is still lacking. Here, we analyzed whether an autoimmune reaction involving the HLA class II proteins HLA-DQ and -DR, both being strongly associated with UC, could be a disease trigger or driver. To this end, genotype data derived from whole exome sequencing and genome-wide SNP array data of 863 German UC patients as well as 4,185 healthy controls were analyzed. Association analyses identified novel variants in the NOD2 and SNX20 genes to be linked with UC and confirmed known HLA allele associations. Employing the genetic data, we generated patient-specific self-immunopeptidomes and in sili co predicted HLA-peptide binding. Peptidome-wide association analyses of peptide binding preferences in a set of candidate proteins yielded significant associations with 234 specific peptides. Interestingly, none of those peptides showed a differential presence in case and control samples. The disease-associated candidate peptides predicted to be presented by risk HLA proteins contained predominantly aromatic amino acids. In contrast, protective HLA proteins were predicted to bind peptides enriched in acidic amino acids. In summary, we present a proof-of-concept immunogenetic analysis that contributes to a better understanding of the HLA in UC.
Open AccessGenome-wide analysis of individual coding variants and HLA-II-associated self-immunopeptidomes in ulcerative colitis
Genome wide association studies contributed to a better understanding of the etiology of inflammatory bowel disease (IBD). While over 240 genetic associations with IBD have since been identified, functional follow-up studies are still in their infancy with the overall pathogenesis of IBD remaining unsolved. E.g., a functional understanding of the genetic association between the human leukocyte antigen (HLA) region and ulcerative colitis (UC) – one subtypes of IBD – is still lacking. Here, we analyzed whether an autoimmune reaction involving the HLA class II proteins HLA-DQ and -DR, both being strongly associated with UC, could be a disease trigger or driver. To this end, genotype data derived from whole exome sequencing and genome-wide SNP array data of 863 German UC patients as well as 4,185 healthy controls were analyzed. Association analyses identified novel variants in the NOD2 and SNX20 genes to be linked with UC and confirmed known HLA allele associations. Employing the genetic data, we generated patient-specific self-immunopeptidomes and in sili co predicted HLA-peptide binding. Peptidome-wide association analyses of peptide binding preferences in a set of candidate proteins yielded significant associations with 234 specific peptides. Interestingly, none of those peptides showed a differential presence in case and control samples. The disease-associated candidate peptides predicted to be presented by risk HLA proteins contained predominantly aromatic amino acids. In contrast, protective HLA proteins were predicted to bind peptides enriched in acidic amino acids. In summary, we present a proof-of-concept immunogenetic analysis that contributes to a better understanding of the HLA in UC.